Figure 1.
Platelets synthesize the Shh ligand upon agonist stimulation. (A) Amplification chart representing Cq of mRNAs in platelets as indicated. (B) Synthesis of Shh in platelets treated with thrombin (Thr) (0.5 U/mL) for varying time points. PVDF membrane developed for Shh was stripped and reprobed for β-actin. (C) Corresponding densitometric analysis normalized against β-actin. (D-E) Surface externalization of Shh in thrombin (1 U/mL)-induced platelets. (F-G) Shh exposure on EVs released from thrombin (1 U/mL)-stimulated platelets. RP, resting platelets. Data are represented as mean ± standard error of the mean of 3 to 5 independent experiments. *P < .05 as compared with resting platelets; #P < .05 as compared with thrombin-stimulated platelets.

Platelets synthesize the Shh ligand upon agonist stimulation. (A) Amplification chart representing Cq of mRNAs in platelets as indicated. (B) Synthesis of Shh in platelets treated with thrombin (Thr) (0.5 U/mL) for varying time points. PVDF membrane developed for Shh was stripped and reprobed for β-actin. (C) Corresponding densitometric analysis normalized against β-actin. (D-E) Surface externalization of Shh in thrombin (1 U/mL)-induced platelets. (F-G) Shh exposure on EVs released from thrombin (1 U/mL)-stimulated platelets. RP, resting platelets. Data are represented as mean ± standard error of the mean of 3 to 5 independent experiments. *P < .05 as compared with resting platelets; #P < .05 as compared with thrombin-stimulated platelets.

Close Modal

or Create an Account

Close Modal
Close Modal